Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors

Bone Marrow Transplant. 2009 Nov;44(9):613-5. doi: 10.1038/bmt.2009.60. Epub 2009 Mar 23.

Authors

E Brissot, P Chevallier, T Guillaume, J Delaunay, S Ayari, V Dubruille, S Le Gouill, B Mahe, T Gastinne, N Blin, B Saulquin, G Flandrois, A Devys, V Stocco, A Cesbron, F Dehaut, P Moreau, J-L Harousseau, M Mohty

PMID: 19308036
DOI: 10.1038/bmt.2009.60

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Antigens, CD34 / blood
Female
Granulocyte Colony-Stimulating Factor / administration & dosage*
Granulocyte Colony-Stimulating Factor / adverse effects
Hematopoietic Stem Cell Mobilization / methods*
Hematopoietic Stem Cell Transplantation / methods*
Hematopoietic Stem Cells / cytology
Hematopoietic Stem Cells / drug effects*
Humans
Leukapheresis / methods
Male
Middle Aged
Tissue Donors
Transplantation Conditioning
Treatment Outcome
Young Adult

Substances

Antigens, CD34
Granulocyte Colony-Stimulating Factor